Public Health

29 03, 2017

Argentina’s Patent Office signs bilateral agreement with the US harming public health and national laws

2017-03-29T20:16:15-03:00miércoles, 29 marzo, 2017|Access to Medicines, Argentina, Health Safeguards, Intellectual Property, Public Health|

The Argentinian National Institute of Industrial Property (INPI, by its acronym in Spanish) signed a bilateral agreement with the US Patent Office on February 13th that includes reciprocal acceptance of patenting results of both offices. The news are grave and serious as the "Patent Prosecution Highway Between USPTO and INPI-Argentina" effectively repeals the Argentine Patent

5 02, 2016

FGEP and other Latin American organizations requested a Thematic Hearing at the Inter-American Commission on Human Rights

2018-02-05T10:36:13-03:00viernes, 5 febrero, 2016|Advocacy, Direct Action, Hepatitis C, HIV, Medicines, Public Health, RedLAM|

Por: Julia Varela   GEP Foundation (FGEP), along with more than 20 other civil society organizations from different countries in Latin America committed to defending the right to health, requested last January 18th a Thematic Hearing at the Inter-American Commission on Human Rights (IACHR) on the issue of lack of access to medicines. The request

11 09, 2015

UNAIDS “4th 90”: Affordability of Medicines

2015-11-04T16:38:17-03:00viernes, 11 septiembre, 2015|909090 Strategy, Access to Medicines, Argentina, Medicines, Ministry of Health, Public Health, UNAIDS|

UNAIDS has seen Argentina´s proposal to add a 4th “90” to its 909090 Strategy as a model to be implemented worldwide Buenos aires, September 2015 – UNAIDS´s Executive Director, Michel Sidibé, visit Argentina and Chile in his first time visit to Latin American region as part of a global tour to promote 90-90-90 strategy which

27 08, 2015

People living with HepC denounced high prices of the pharmaceutical industry

2015-11-04T20:18:54-03:00jueves, 27 agosto, 2015|Direct Action, Hepatitis C, Intellectual Property, Patent opposition, Public Health|

Buenos Aires, August 27th 2015 - Members of Grupo Efecto Positivo Foundation (FGEP) accompanied by other civil society organizations and representatives held a direct action during the 2015 Hepatitis International Symposium organized by Fundación Huesped. The action aimed to denounce monopolies and high prices of drugs to treat hepatitis C and took place during the presentation of Dr.

29 07, 2015

World Viral Hepatitis Day: Challenges and Progress in Argentina for access to treatments that cure

2015-11-04T14:06:31-03:00miércoles, 29 julio, 2015|Access to Medicines, Advocacy, Hepatitis C, Intellectual Property, Ministry of Health, Public Health|

BUENOS AIRES - On World Viral Hepatitis Day, Fundación Grupo Efecto Positivo (FGEP) held a meeting with officials from Argentina’s Ministry of Health, articulating and coordinating actions and strategies that promote access to sofosbuvir, an essential drug for Hepatitis C treatment. The need for joint action originates from the great challenge both Argentina and Latin

22 07, 2015

FGEP and the Ministry of Industry agree on agenda to jointly work for Access to Medicines

2015-11-04T13:56:27-03:00miércoles, 22 julio, 2015|Access to Medicines, Health Safeguards, Intellectual Property, Medicines, Public Health|

BUENOS AIRES  – On Tuesday July 21st members of Fundación GEP met with the head of the Ministry of Industry, Lic. Débora Giorgi, and the President of the National Institute of Industrial Property (INPI) Cdor. Mario Aramburu, to analize the topics of the joint agenda on access to medicines and intellectual property. Among these were reviewed the presentations

20 05, 2015

Patent opposition for Sofosbuvir requested in Argentina

2015-11-04T16:41:16-03:00miércoles, 20 mayo, 2015|Access to Medicines, Advocacy, Health Safeguards, Hepatitis C, Public Health|

Organizations of people with hepatitis C have filed an opposition for a patent that would prevent 800,000 people from having access to treatment in Argentina Fundación Grupo Efecto Positivo (FGEP) leads the opposition to pharmaceutical patents movement as a key strategy to ensure access to medicines The growing global movement to guarantee access to medicines

Ir a Arriba